New antiemetic drugsROILA, F; FATIGONI, S.Annals of oncology. 2006, Vol 17, issn 0923-7534, ii96-ii100, SUP2Conference Paper

Palonosetron. ViewpointsSIDDIQUI, M. Asif A; SCOTT, Lesley J; LABIANCA, Roberto M et al.Drugs (Basel). 2004, Vol 64, Num 10, pp 1125-1134, issn 0012-6667, 10 p.Article

Effectiveness of Palonosetron Versus Other Serotonin 5-HT₃ Receptor Antagonists in Triple Antiemetic Regimens During Multiday Highly Emetogenic ChemotherapyKYUNG IM KIM; DONG EUN LEE; CHO, Inhye et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 12, pp 1637-1644, issn 1060-0280, 8 p.Article

Update and new trends in antiemetic therapy: the continuing need for novel therapiesFEYER, P; JORDAN, K.Annals of oncology. 2011, Vol 22, Num 1, pp 30-38, issn 0923-7534, 9 p.Article

Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind studyMOON, Y. E; JOO, J; KIM, J. E et al.British journal of anaesthesia. 2012, Vol 108, Num 3, pp 417-422, issn 0007-0912, 6 p.Article

Determination of palonosetron in human plasma by ultra performance liquid chromatography―tandem mass spectrometry and its application to a pharmacokinetic studySHUYAN YANG; FENG QIN; DAN WANG et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 57, Num C, pp 13-18, issn 0731-7085, 6 p.Article

Determination of palonosetron in human plasma by liquid chromatography-electrospray ionization-mass spectrometryLI DING; YAN CHEN; LIN YANG et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 44, Num 2, pp 575-580, issn 0731-7085, 6 p.Article

Palonosetron Exhibits Unique Molecular Interactions with the 5-HT₃ ReceptorROJAS, Camilo; STATHIS, Marigo; SLUSHER, Barbara et al.Anesthesia and analgesia. 2008, Vol 107, Num 2, pp 469-478, issn 0003-2999, 10 p.Article

Palonosetron triggers 5-HT₃ receptor internalization and causes prolonged inhibition of receptor functionROJAS, Camilo; THOMAS, Ajit G; ALT, Jesse et al.European journal of pharmacology. 2010, Vol 626, Num 2-3, pp 193-199, issn 0014-2999, 7 p.Article

Development and validation of a stability-indicating LC method for determining Palonosetron hydrochloride, its related compounds and degradation products using naphthalethyl stationary phaseVISHNU MURTHY, M; SRINIVAS, Katkam; KUMAR, Ramesh et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 56, Num 2, pp 429-435, issn 0731-7085, 7 p.Article

Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancerKAUSHAL, J; GUPTA, M. C; KAUSHAL, V et al.Singapore medical journal. 2010, Vol 51, Num 11, pp 871-875, issn 0037-5675, 5 p.Article

Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT₃ receptorsMOURA BARBOSA, Arménio J; DERIENZO, Francesca; RAMOS, Maria J et al.European journal of medicinal chemistry. 2010, Vol 45, Num 11, pp 4746-4760, issn 0223-5234, 15 p.Article

Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical studyEISENBERG, P; MACKINTOSH, F. R; RITCH, P et al.Annals of oncology. 2004, Vol 15, Num 2, pp 330-337, issn 0923-7534, 8 p.Article

Enantioseparation of palonosetron hydrochloride by micellar electrokinetic chromatography with sodium cholate as chiral selectorKAN TIAN; HONGLI CHEN; JIANGHONG TANG et al.Journal of chromatography. 2006, Vol 1132, Num 1-2, pp 333-336, issn 0021-9673, 4 p.Article

Effect of low concentration sodium dodecyl sulfate on the electromigration of palonosetron hydrochloride stereoisomers in micellar electrokinetic chromatographyHU, Shao-Qiang; WANG, Gui-Xia; GUO, Wen-Bo et al.Journal of chromatography. 2014, Vol 1342, pp 86-91, issn 0021-9673, 6 p.Article

An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomitingFABI, Alessandra; MALAGUTI, Paola.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 5, pp 629-641, issn 1465-6566, 13 p.Article

palonosétron ^(ALOXI°): Un autre sétron par voie intraveineuse, sans plusLa Revue Prescrire. 2014, Vol 34, Num 363, pp 13-14, issn 0247-7750, 2 p.Article

A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Different Doses of Palonosetron Versus Placebo for Preventing Postoperative Nausea and VomitingCANDIOTTI, Keith A; KOVAC, Anthony L; MELSON, Timothy I et al.Anesthesia and analgesia. 2008, Vol 107, Num 2, pp 445-451, issn 0003-2999, 7 p.Article

Validated Chiral LC Method for the Enantiomeric Separation of Palonosetron HydrochlorideRADHAKRISHNANAND, P; SUBBA RAO, D. V; HIMABINDU, V et al.Chromatographia (Wiesbaden). 2009, Vol 69, Num 3-4, pp 369-373, issn 0009-5893, 5 p.Article

Netupitant and palonosetron trigger NK₁ receptor internalization in NG108-15 cellsTHOMAS, Ajit G; STATHIS, Marigo; ROJAS, Camilo et al.Experimental brain research. 2014, Vol 232, Num 8, pp 2637-2644, issn 0014-4819, 8 p.Conference Paper

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapyAAPRO, M; FABI, A; NOLE, F et al.Annals of oncology. 2010, Vol 21, Num 5, pp 1083-1088, issn 0923-7534, 6 p.Article

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapyMAEMONDO, M; MASUDA, N; SEKINE, I et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1860-1866, issn 0923-7534, 7 p.Article

Pharmacokinetics, metabolism and excretion of intravenous [¹⁴C]-palonosetron in healthy human volunteersSTOLTZ, Randall; PARISI, Simona; SHAH, Ajit et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 8, pp 329-337, issn 0142-2782, 9 p.Article

Daily Palonosetron Is Superior to Ondansetron in the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Acute Myelogenous LeukemiaMATTIUZZI, Gloria N; CORTES, Jorge E; BLAMBLE, Deborah A et al.Cancer. 2010, Vol 116, Num 24, pp 5659-5666, issn 0008-543X, 8 p.Article

Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT₃ receptor antagonist: Results of a phase III, single-dose trial versus dolasetronEISENBERG, Peter; FIGUEROA-VADILLO, Jazmin; ZAMORA, Rosalio et al.Cancer. 2003, Vol 98, Num 11, pp 2473-2482, issn 0008-543X, 10 p.Article